BindingDB logo
myBDB logout

Articleid 8836

Compile data set for download or QSAR
Found 101 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kJ/mole		IC50
nM		Kd
nM		EC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM420298
PNG
(PF-00835231 | PF-0835231 | WO2005113580-Ex-02 | WO...)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O6/c1-13(2)9-18(23(32)27-17(20(30)12-29)10-14-7-8-25-22(14)31)28-24(33)19-11-15-16(26-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,26,29H,7-10,12H2,1-3H3,(H,25,31)(H,27,32)(H,28,33)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
Purchase

PDB
UniChem
WIPO
n/an/a 4n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423450
PNG
(WO2005113580-Ex-52)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CNC(=O)c1ccccc1C#N
Show InChI InChI=1S/C32H36N6O6/c1-18(2)13-25(38-32(43)26-15-22-23(36-26)9-6-10-28(22)44-3)31(42)37-24(14-19-11-12-34-29(19)40)27(39)17-35-30(41)21-8-5-4-7-20(21)16-33/h4-10,15,18-19,24-25,36H,11-14,17H2,1-3H3,(H,34,40)(H,35,41)(H,37,42)(H,38,43)/t19-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 17n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423465
PNG
(WO2006061714, P38.8 | WO2006061714-ID-10 | cmdc.20...)
Show SMILES CC(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C22H28N4O4/c1-13(2)9-18(21(29)24-16(12-27)10-15-7-8-23-20(15)28)26-22(30)19-11-14-5-3-4-6-17(14)25-19/h3-6,11-13,15-16,18,25H,7-10H2,1-2H3,(H,23,28)(H,24,29)(H,26,30)/t15-,16-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 20n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423414
PNG
(WO2005113580-Ex-08 | cmdc.202100576, 24c)
Show SMILES CCCC[C@H](NC(=O)c1cc2c(OC)cccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O6/c1-3-4-6-17(23(32)28-18(20(30)13-29)11-14-9-10-25-22(14)31)27-24(33)19-12-15-16(26-19)7-5-8-21(15)34-2/h5,7-8,12,14,17-18,26,29H,3-4,6,9-11,13H2,1-2H3,(H,25,31)(H,27,33)(H,28,32)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 20n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423420
PNG
(WO2005113580-Ex-16 | cmdc.202100576, 24b)
Show SMILES CC(C)(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O5/c1-24(2,3)12-19(28-22(32)18-10-14-6-4-5-7-16(14)26-18)23(33)27-17(20(30)13-29)11-15-8-9-25-21(15)31/h4-7,10,15,17,19,26,29H,8-9,11-13H2,1-3H3,(H,25,31)(H,27,33)(H,28,32)/t15-,17-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 20n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423418
PNG
(WO2005113580-Ex-13)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C25H34N4O6/c1-25(2,3)12-19(24(34)28-17(20(31)13-30)10-14-8-9-26-22(14)32)29-23(33)18-11-15-16(27-18)6-5-7-21(15)35-4/h5-7,11,14,17,19,27,30H,8-10,12-13H2,1-4H3,(H,26,32)(H,28,34)(H,29,33)/t14-,17-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 23n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423429
PNG
(WO2005113580-Ex-27)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C27H36N4O6/c1-37-24-9-5-8-19-18(24)14-22(29-19)27(36)31-21(12-16-6-3-2-4-7-16)26(35)30-20(23(33)15-32)13-17-10-11-28-25(17)34/h5,8-9,14,16-17,20-21,29,32H,2-4,6-7,10-13,15H2,1H3,(H,28,34)(H,30,35)(H,31,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 25n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423464
PNG
(WO2006061714, P38.7 | WO2006061714-ID-09 | cmdc.20...)
Show SMILES CC(C)C[C@H](NC(=O)c1nc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C21H27N5O4/c1-12(2)9-17(20(29)23-14(11-27)10-13-7-8-22-19(13)28)26-21(30)18-24-15-5-3-4-6-16(15)25-18/h3-6,11-14,17H,7-10H2,1-2H3,(H,22,28)(H,23,29)(H,24,25)(H,26,30)/t13-,14-,17-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 32n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423432
PNG
(WO2005113580-Ex-30)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COCc1ccccc1
Show InChI InChI=1S/C32H40N4O6/c1-32(2,3)17-26(36-30(39)25-16-22-23(34-25)11-8-12-28(22)41-4)31(40)35-24(15-21-13-14-33-29(21)38)27(37)19-42-18-20-9-6-5-7-10-20/h5-12,16,21,24,26,34H,13-15,17-19H2,1-4H3,(H,33,38)(H,35,40)(H,36,39)/t21-,24-,26-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 32n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423415
PNG
(WO2005113580-Ex-10)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CCC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C25H34N4O6/c1-14(2)7-8-18(24(33)29-19(21(31)13-30)11-15-9-10-26-23(15)32)28-25(34)20-12-16-17(27-20)5-4-6-22(16)35-3/h4-6,12,14-15,18-19,27,30H,7-11,13H2,1-3H3,(H,26,32)(H,28,34)(H,29,33)/t15-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 34n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423417
PNG
(WO2005113580-Ex-11)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CCC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C26H36N4O6/c1-15(2)8-9-19(29-26(34)21-13-17-18(28-21)6-5-7-23(17)36-4)25(33)30-20(22(31)14-35-3)12-16-10-11-27-24(16)32/h5-7,13,15-16,19-20,28H,8-12,14H2,1-4H3,(H,27,32)(H,29,34)(H,30,33)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 36n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423411
PNG
(WO2005113580-Ex-05 | cmdc.202100576, 6c)
Show SMILES CC(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C23H30N4O5/c1-13(2)9-18(27-23(32)19-10-14-5-3-4-6-16(14)25-19)22(31)26-17(20(29)12-28)11-15-7-8-24-21(15)30/h3-6,10,13,15,17-18,25,28H,7-9,11-12H2,1-2H3,(H,24,30)(H,26,31)(H,27,32)/t15-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 38n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423469
PNG
(WO2006061714, P39.4 | WO2006061714-ID-14 | cmdc.20...)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N(C)C)C=O
Show InChI InChI=1S/C23H32N4O5/c1-14(2)11-18(22(30)24-15(13-28)9-10-21(29)27(3)4)26-23(31)19-12-16-17(25-19)7-6-8-20(16)32-5/h6-8,12-15,18,25H,9-11H2,1-5H3,(H,24,30)(H,26,31)/t15-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 50n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423410
PNG
(WO2005113580-Ex-03 | cmdc.202100576, 6d)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C25H34N4O6/c1-14(2)10-19(29-25(33)20-12-16-17(27-20)6-5-7-22(16)35-4)24(32)28-18(21(30)13-34-3)11-15-8-9-26-23(15)31/h5-7,12,14-15,18-19,27H,8-11,13H2,1-4H3,(H,26,31)(H,28,32)(H,29,33)/t15-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 51n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423441
PNG
(WO2005113580-Ex-43)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(cc1)C#N
Show InChI InChI=1S/C32H35N5O7/c1-18(2)13-25(37-31(41)26-15-22-23(35-26)5-4-6-28(22)43-3)30(40)36-24(14-21-11-12-34-29(21)39)27(38)17-44-32(42)20-9-7-19(16-33)8-10-20/h4-10,15,18,21,24-25,35H,11-14,17H2,1-3H3,(H,34,39)(H,36,40)(H,37,41)/t21-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 53n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423419
PNG
(WO2005113580-Ex-14)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C26H36N4O6/c1-26(2,3)13-20(30-24(33)19-12-16-17(28-19)7-6-8-22(16)36-5)25(34)29-18(21(31)14-35-4)11-15-9-10-27-23(15)32/h6-8,12,15,18,20,28H,9-11,13-14H2,1-5H3,(H,27,32)(H,29,34)(H,30,33)/t15-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 54n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423466
PNG
(WO2006061714, P39.1 | WO2006061714-ID-11 | cmdc.20...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C26H38N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,14,16-17,19-22H,10-13,15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 60n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423442
PNG
(WO2005113580-Ex-44)
Show SMILES COc1ccc(cc1)C(=O)OCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C32H38N4O8/c1-18(2)14-25(36-31(40)26-16-22-23(34-26)6-5-7-28(22)43-4)30(39)35-24(15-20-12-13-33-29(20)38)27(37)17-44-32(41)19-8-10-21(42-3)11-9-19/h5-11,16,18,20,24-25,34H,12-15,17H2,1-4H3,(H,33,38)(H,35,39)(H,36,40)/t20-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 79n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423440
PNG
(WO2005113580-Ex-42)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(F)cc1
Show InChI InChI=1S/C31H35FN4O7/c1-17(2)13-24(36-30(40)25-15-21-22(34-25)5-4-6-27(21)42-3)29(39)35-23(14-19-11-12-33-28(19)38)26(37)16-43-31(41)18-7-9-20(32)10-8-18/h4-10,15,17,19,23-24,34H,11-14,16H2,1-3H3,(H,33,38)(H,35,39)(H,36,40)/t19-,23-,24-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 82n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423439
PNG
(WO2005113580-Ex-41)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(C)cc1
Show InChI InChI=1S/C32H38N4O7/c1-18(2)14-25(36-31(40)26-16-22-23(34-26)6-5-7-28(22)42-4)30(39)35-24(15-21-12-13-33-29(21)38)27(37)17-43-32(41)20-10-8-19(3)9-11-20/h5-11,16,18,21,24-25,34H,12-15,17H2,1-4H3,(H,33,38)(H,35,39)(H,36,40)/t21-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 82n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423438
PNG
(WO2005113580-Ex-40)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccccc1
Show InChI InChI=1S/C31H36N4O7/c1-18(2)14-24(35-30(39)25-16-21-22(33-25)10-7-11-27(21)41-3)29(38)34-23(15-20-12-13-32-28(20)37)26(36)17-42-31(40)19-8-5-4-6-9-19/h4-11,16,18,20,23-24,33H,12-15,17H2,1-3H3,(H,32,37)(H,34,38)(H,35,39)/t20-,23-,24-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 86n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423423
PNG
(WO2005113580-Ex-20)
Show SMILES CC(C)(C)C[C@H](NC(=O)[C@H]1CCCO1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C20H33N3O6/c1-20(2,3)10-14(23-19(28)16-5-4-8-29-16)18(27)22-13(15(25)11-24)9-12-6-7-21-17(12)26/h12-14,16,24H,4-11H2,1-3H3,(H,21,26)(H,22,27)(H,23,28)/t12-,13-,14-,16+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 91n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423453
PNG
(WO2005113580-Ex-55)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CN=[N+]=[N-]
Show InChI InChI=1S/C24H31N7O5/c1-13(2)9-18(30-24(35)19-11-15-16(28-19)5-4-6-21(15)36-3)23(34)29-17(20(32)12-27-31-25)10-14-7-8-26-22(14)33/h4-6,11,13-14,17-18,28H,7-10,12H2,1-3H3,(H,26,33)(H,29,34)(H,30,35)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 101n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423426
PNG
(WO2005113580-Ex-23 | cmdc.202100576, 6e)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C27H30N4O6/c1-37-24-9-5-8-19-18(24)14-22(29-19)27(36)31-21(12-16-6-3-2-4-7-16)26(35)30-20(23(33)15-32)13-17-10-11-28-25(17)34/h2-9,14,17,20-21,29,32H,10-13,15H2,1H3,(H,28,34)(H,30,35)(H,31,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 103n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423431
PNG
(WO2005113580-Ex-29 | cmdc.202100576, 6d)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C25H34N4O6/c1-14(2)10-20(24(33)28-18(21(31)13-30)11-15-8-9-26-23(15)32)29(3)25(34)19-12-16-17(27-19)6-5-7-22(16)35-4/h5-7,12,14-15,18,20,27,30H,8-11,13H2,1-4H3,(H,26,32)(H,28,33)/t15-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 105n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423421
PNG
(WO2005113580-Ex-17)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C25H34N4O5/c1-25(2,3)13-20(29-23(32)19-11-15-7-5-6-8-17(15)27-19)24(33)28-18(21(30)14-34-4)12-16-9-10-26-22(16)31/h5-8,11,16,18,20,27H,9-10,12-14H2,1-4H3,(H,26,31)(H,28,33)(H,29,32)/t16-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 105n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423455
PNG
(WO2005113580-Ex-57)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CNS(C)(=O)=O
Show InChI InChI=1S/C25H35N5O7S/c1-14(2)10-19(30-25(34)20-12-16-17(28-20)6-5-7-22(16)37-3)24(33)29-18(11-15-8-9-26-23(15)32)21(31)13-27-38(4,35)36/h5-7,12,14-15,18-19,27-28H,8-11,13H2,1-4H3,(H,26,32)(H,29,33)(H,30,34)/t15-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 107n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423422
PNG
(WO2005113580-Ex-18)
Show SMILES CCOCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C26H36N4O5/c1-5-35-15-22(31)19(13-17-10-11-27-23(17)32)29-25(34)21(14-26(2,3)4)30-24(33)20-12-16-8-6-7-9-18(16)28-20/h6-9,12,17,19,21,28H,5,10-11,13-15H2,1-4H3,(H,27,32)(H,29,34)(H,30,33)/t17-,19-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 112n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423412
PNG
(WO2005113580-Ex-06)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C24H32N4O5/c1-14(2)10-19(28-24(32)20-11-15-6-4-5-7-17(15)26-20)23(31)27-18(21(29)13-33-3)12-16-8-9-25-22(16)30/h4-7,11,14,16,18-19,26H,8-10,12-13H2,1-3H3,(H,25,30)(H,27,31)(H,28,32)/t16-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 131n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423428
PNG
(WO2005113580-Ex-26)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COCc1ccccc1
Show InChI InChI=1S/C34H42N4O6/c1-43-31-14-8-13-26-25(31)19-29(36-26)34(42)38-28(17-22-9-4-2-5-10-22)33(41)37-27(18-24-15-16-35-32(24)40)30(39)21-44-20-23-11-6-3-7-12-23/h3,6-8,11-14,19,22,24,27-28,36H,2,4-5,9-10,15-18,20-21H2,1H3,(H,35,40)(H,37,41)(H,38,42)/t24-,27-,28-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 133n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423437
PNG
(WO2005113580-Ex-39)
Show SMILES CC(C)(C)C[C@H](NC(=O)[C@H]1CCCO1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(Cl)cccc1Cl
Show InChI InChI=1S/C27H35Cl2N3O7/c1-27(2,3)13-19(32-25(36)21-8-5-11-38-21)24(35)31-18(12-15-9-10-30-23(15)34)20(33)14-39-26(37)22-16(28)6-4-7-17(22)29/h4,6-7,15,18-19,21H,5,8-14H2,1-3H3,(H,30,34)(H,31,35)(H,32,36)/t15-,18-,19-,21+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 133n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423427
PNG
(WO2005113580-Ex-25)
Show SMILES CC(C)C[C@H](N(C)C(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O5/c1-14(2)10-20(28(3)24(33)19-11-15-6-4-5-7-17(15)26-19)23(32)27-18(21(30)13-29)12-16-8-9-25-22(16)31/h4-7,11,14,16,18,20,26,29H,8-10,12-13H2,1-3H3,(H,25,31)(H,27,32)/t16-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 152n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423445
PNG
(WO2005113580-Ex-47)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(C)cccc1C
Show InChI InChI=1S/C33H40N4O7/c1-18(2)14-25(37-32(41)26-16-22-23(35-26)10-7-11-28(22)43-5)31(40)36-24(15-21-12-13-34-30(21)39)27(38)17-44-33(42)29-19(3)8-6-9-20(29)4/h6-11,16,18,21,24-25,35H,12-15,17H2,1-5H3,(H,34,39)(H,36,40)(H,37,41)/t21-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 160n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423435
PNG
(WO2005113580-Ex-37 | cmdc.202100576, 24e)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)C1CC1
Show InChI InChI=1S/C28H36N4O7/c1-15(2)11-21(32-27(36)22-13-18-19(30-22)5-4-6-24(18)38-3)26(35)31-20(12-17-9-10-29-25(17)34)23(33)14-39-28(37)16-7-8-16/h4-6,13,15-17,20-21,30H,7-12,14H2,1-3H3,(H,29,34)(H,31,35)(H,32,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 180n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423433
PNG
(WO2005113580-Ex-34)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N(C)C)C(=O)CO
Show InChI InChI=1S/C24H34N4O6/c1-14(2)11-18(23(32)26-17(20(30)13-29)9-10-22(31)28(3)4)27-24(33)19-12-15-16(25-19)7-6-8-21(15)34-5/h6-8,12,14,17-18,25,29H,9-11,13H2,1-5H3,(H,26,32)(H,27,33)/t17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 190n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423447
PNG
(WO2005113580-Ex-49)
Show SMILES COc1cccc(OC)c1C(=O)OCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C33H40N4O9/c1-18(2)14-23(37-32(41)24-16-20-21(35-24)8-6-9-26(20)43-3)31(40)36-22(15-19-12-13-34-30(19)39)25(38)17-46-33(42)29-27(44-4)10-7-11-28(29)45-5/h6-11,16,18-19,22-23,35H,12-15,17H2,1-5H3,(H,34,39)(H,36,40)(H,37,41)/t19-,22-,23-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 210n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423434
PNG
(WO2005113580-Ex-36)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(C)=O
Show InChI InChI=1S/C26H34N4O7/c1-14(2)10-20(30-26(35)21-12-17-18(28-21)6-5-7-23(17)36-4)25(34)29-19(22(32)13-37-15(3)31)11-16-8-9-27-24(16)33/h5-7,12,14,16,19-20,28H,8-11,13H2,1-4H3,(H,27,33)(H,29,34)(H,30,35)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 220n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423436
PNG
(WO2005113580-Ex-38)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)C(C)(C)C
Show InChI InChI=1S/C29H40N4O7/c1-16(2)12-21(33-27(37)22-14-18-19(31-22)8-7-9-24(18)39-6)26(36)32-20(13-17-10-11-30-25(17)35)23(34)15-40-28(38)29(3,4)5/h7-9,14,16-17,20-21,31H,10-13,15H2,1-6H3,(H,30,35)(H,32,36)(H,33,37)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 230n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423430
PNG
(WO2005113580-Ex-28)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COCc1ccccc1
Show InChI InChI=1S/C32H40N4O6/c1-20(2)15-27(36(3)32(40)26-17-23-24(34-26)11-8-12-29(23)41-4)31(39)35-25(16-22-13-14-33-30(22)38)28(37)19-42-18-21-9-6-5-7-10-21/h5-12,17,20,22,25,27,34H,13-16,18-19H2,1-4H3,(H,33,38)(H,35,39)/t22-,25-,27-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 927n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423424
PNG
(WO2005113580-Ex-21)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H]1CCCO1
Show InChI InChI=1S/C21H35N3O6/c1-21(2,3)11-15(24-20(28)17-6-5-9-30-17)19(27)23-14(16(25)12-29-4)10-13-7-8-22-18(13)26/h13-15,17H,5-12H2,1-4H3,(H,22,26)(H,23,27)(H,24,28)/t13-,14-,15-,17+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 1.08E+3n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423451
PNG
(WO2005113580-Ex-53)
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(Cl)cccc1Cl
Show InChI InChI=1S/C23H29Cl2N3O6/c1-12(2)9-18(27-13(3)29)22(32)28-17(10-14-7-8-26-21(14)31)19(30)11-34-23(33)20-15(24)5-4-6-16(20)25/h4-6,12,14,17-18H,7-11H2,1-3H3,(H,26,31)(H,27,29)(H,28,32)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 1.28E+3n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423463
PNG
(WO2006061714-ID-07)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)NC(C[C@@H]1CCNC1=O)C(C)=O
Show InChI InChI=1S/C24H32N4O5/c1-13(2)10-19(23(31)27-18(14(3)29)11-15-8-9-25-22(15)30)28-24(32)20-12-16-17(26-20)6-5-7-21(16)33-4/h5-7,12-13,15,18-19,26H,8-11H2,1-4H3,(H,25,30)(H,27,31)(H,28,32)/t15-,18?,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 2.30E+3n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423454
PNG
(WO2005113580-Ex-56)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CNC(C)=O
Show InChI InChI=1S/C26H35N5O6/c1-14(2)10-20(31-26(36)21-12-17-18(29-21)6-5-7-23(17)37-4)25(35)30-19(22(33)13-28-15(3)32)11-16-8-9-27-24(16)34/h5-7,12,14,16,19-20,29H,8-11,13H2,1-4H3,(H,27,34)(H,28,32)(H,30,35)(H,31,36)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 2.65E+3n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423467
PNG
(WO2006061714, P39.2 | WO2006061714-ID-12)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O
Show InChI InChI=1S/C26H40N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,16-17,19-22,31H,10-15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
PDB
UniChem
WIPO
n/an/a 6.80E+4n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423468
PNG
(WO2006061714, P39.3 | WO2006061714-ID-13)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(C)=O)C(C)C)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O
Show InChI InChI=1S/C20H36N4O5/c1-11(2)8-16(24-20(29)17(12(3)4)22-13(5)26)19(28)23-15(10-25)9-14-6-7-21-18(14)27/h11-12,14-17,25H,6-10H2,1-5H3,(H,21,27)(H,22,26)(H,23,28)(H,24,29)/t14-,15-,16-,17-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a 9.70E+4n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423470
PNG
(WO2006061714, P39.5 | WO2006061714-ID-15)
Show SMILES CON(C)C(=O)[C@H](CCC(=O)N(C)C)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C25H37N5O6/c1-15(2)13-19(28-24(33)20-14-16-17(26-20)9-8-10-21(16)35-6)23(32)27-18(25(34)30(5)36-7)11-12-22(31)29(3)4/h8-10,14-15,18-19,26H,11-13H2,1-7H3,(H,27,32)(H,28,33)/t18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/a>1.00E+5n/an/an/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
The SARS 3CLpro FRET assay measures the protease catalyzed cleavage of TAMRA- SITSAVLQSGFRKMK-(DABCYL)-OH to TAMRA - SITSAVLQ and SGFRKMK- (DABCYL)-O...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423463
PNG
(WO2006061714-ID-07)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)NC(C[C@@H]1CCNC1=O)C(C)=O
Show InChI InChI=1S/C24H32N4O5/c1-13(2)10-19(23(31)27-18(14(3)29)11-15-8-9-25-22(15)30)28-24(32)20-12-16-17(26-20)6-5-7-21(16)33-4/h5-7,12-13,15,18-19,26H,8-11H2,1-4H3,(H,25,30)(H,27,31)(H,28,32)/t15-,18?,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 9.15E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423423
PNG
(WO2005113580-Ex-20)
Show SMILES CC(C)(C)C[C@H](NC(=O)[C@H]1CCCO1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C20H33N3O6/c1-20(2,3)10-14(23-19(28)16-5-4-8-29-16)18(27)22-13(15(25)11-24)9-12-6-7-21-17(12)26/h12-14,16,24H,4-11H2,1-3H3,(H,21,26)(H,22,27)(H,23,28)/t12-,13-,14-,16+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 2.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423426
PNG
(WO2005113580-Ex-23 | cmdc.202100576, 6e)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C27H30N4O6/c1-37-24-9-5-8-19-18(24)14-22(29-19)27(36)31-21(12-16-6-3-2-4-7-16)26(35)30-20(23(33)15-32)13-17-10-11-28-25(17)34/h2-9,14,17,20-21,29,32H,10-13,15H2,1H3,(H,28,34)(H,30,35)(H,31,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 4.70E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423429
PNG
(WO2005113580-Ex-27)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C27H36N4O6/c1-37-24-9-5-8-19-18(24)14-22(29-19)27(36)31-21(12-16-6-3-2-4-7-16)26(35)30-20(23(33)15-32)13-17-10-11-28-25(17)34/h5,8-9,14,16-17,20-21,29,32H,2-4,6-7,10-13,15H2,1H3,(H,28,34)(H,30,35)(H,31,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.40E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423436
PNG
(WO2005113580-Ex-38)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)C(C)(C)C
Show InChI InChI=1S/C29H40N4O7/c1-16(2)12-21(33-27(37)22-14-18-19(31-22)8-7-9-24(18)39-6)26(36)32-20(13-17-10-11-30-25(17)35)23(34)15-40-28(38)29(3,4)5/h7-9,14,16-17,20-21,31H,10-13,15H2,1-6H3,(H,30,35)(H,32,36)(H,33,37)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.40E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423443
PNG
(WO2005113580-Ex-45)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(Cl)cc1
Show InChI InChI=1S/C31H35ClN4O7/c1-17(2)13-24(36-30(40)25-15-21-22(34-25)5-4-6-27(21)42-3)29(39)35-23(14-19-11-12-33-28(19)38)26(37)16-43-31(41)18-7-9-20(32)10-8-18/h4-10,15,17,19,23-24,34H,11-14,16H2,1-3H3,(H,33,38)(H,35,39)(H,36,40)/t19-,23-,24-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.30E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423451
PNG
(WO2005113580-Ex-53)
Show SMILES CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(Cl)cccc1Cl
Show InChI InChI=1S/C23H29Cl2N3O6/c1-12(2)9-18(27-13(3)29)22(32)28-17(10-14-7-8-26-21(14)31)19(30)11-34-23(33)20-15(24)5-4-6-16(20)25/h4-6,12,14,17-18H,7-11H2,1-3H3,(H,26,31)(H,27,29)(H,28,32)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 7.00E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423458
PNG
(WO2005113580-Ex-61)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CN(C)C
Show InChI InChI=1S/C26H37N5O5/c1-15(2)11-20(30-26(35)21-13-17-18(28-21)7-6-8-23(17)36-5)25(34)29-19(22(32)14-31(3)4)12-16-9-10-27-24(16)33/h6-8,13,15-16,19-20,28H,9-12,14H2,1-5H3,(H,27,33)(H,29,34)(H,30,35)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a>1.00E+5n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423410
PNG
(WO2005113580-Ex-03 | cmdc.202100576, 6d)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C25H34N4O6/c1-14(2)10-19(29-25(33)20-12-16-17(27-20)6-5-7-22(16)35-4)24(32)28-18(21(30)13-34-3)11-15-8-9-26-23(15)31/h5-7,12,14-15,18-19,27H,8-11,13H2,1-4H3,(H,26,31)(H,28,32)(H,29,33)/t15-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.10E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423462
PNG
(WO2006061714, P38.2 | WO2006061714-ID-04)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C23H30N4O5/c1-13(2)9-18(22(30)25-15(12-28)10-14-7-8-24-21(14)29)27-23(31)19-11-16-17(26-19)5-4-6-20(16)32-3/h4-6,11-15,18,26H,7-10H2,1-3H3,(H,24,29)(H,25,30)(H,27,31)/t14-,15-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.40E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423408
PNG
(WO2005113580-Ex-01)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CCl
Show InChI InChI=1S/C24H31ClN4O5/c1-13(2)9-18(23(32)28-17(20(30)12-25)10-14-7-8-26-22(14)31)29-24(33)19-11-15-16(27-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,27H,7-10,12H2,1-3H3,(H,26,31)(H,28,32)(H,29,33)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423418
PNG
(WO2005113580-Ex-13)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C25H34N4O6/c1-25(2,3)12-19(24(34)28-17(20(31)13-30)10-14-8-9-26-22(14)32)29-23(33)18-11-15-16(27-18)6-5-7-21(15)35-4/h5-7,11,14,17,19,27,30H,8-10,12-13H2,1-4H3,(H,26,32)(H,28,34)(H,29,33)/t14-,17-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.10E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423428
PNG
(WO2005113580-Ex-26)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COCc1ccccc1
Show InChI InChI=1S/C34H42N4O6/c1-43-31-14-8-13-26-25(31)19-29(36-26)34(42)38-28(17-22-9-4-2-5-10-22)33(41)37-27(18-24-15-16-35-32(24)40)30(39)21-44-20-23-11-6-3-7-12-23/h3,6-8,11-14,19,22,24,27-28,36H,2,4-5,9-10,15-18,20-21H2,1H3,(H,35,40)(H,37,41)(H,38,42)/t24-,27-,28-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.80E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423435
PNG
(WO2005113580-Ex-37 | cmdc.202100576, 24e)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)C1CC1
Show InChI InChI=1S/C28H36N4O7/c1-15(2)11-21(32-27(36)22-13-18-19(30-22)5-4-6-24(18)38-3)26(35)31-20(12-17-9-10-29-25(17)34)23(33)14-39-28(37)16-7-8-16/h4-6,13,15-17,20-21,30H,7-12,14H2,1-3H3,(H,29,34)(H,31,35)(H,32,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 9.30E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423437
PNG
(WO2005113580-Ex-39)
Show SMILES CC(C)(C)C[C@H](NC(=O)[C@H]1CCCO1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(Cl)cccc1Cl
Show InChI InChI=1S/C27H35Cl2N3O7/c1-27(2,3)13-19(32-25(36)21-8-5-11-38-21)24(35)31-18(12-15-9-10-30-23(15)34)20(33)14-39-26(37)22-16(28)6-4-7-17(22)29/h4,6-7,15,18-19,21H,5,8-14H2,1-3H3,(H,30,34)(H,31,35)(H,32,36)/t15-,18-,19-,21+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 2.30E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423464
PNG
(WO2006061714, P38.7 | WO2006061714-ID-09 | cmdc.20...)
Show SMILES CC(C)C[C@H](NC(=O)c1nc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C21H27N5O4/c1-12(2)9-17(20(29)23-14(11-27)10-13-7-8-22-19(13)28)26-21(30)18-24-15-5-3-4-6-16(15)25-18/h3-6,11-14,17H,7-10H2,1-2H3,(H,22,28)(H,23,29)(H,24,25)(H,26,30)/t13-,14-,17-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.60E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423414
PNG
(WO2005113580-Ex-08 | cmdc.202100576, 24c)
Show SMILES CCCC[C@H](NC(=O)c1cc2c(OC)cccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O6/c1-3-4-6-17(23(32)28-18(20(30)13-29)11-14-9-10-25-22(14)31)27-24(33)19-12-15-16(26-19)7-5-8-21(15)34-2/h5,7-8,12,14,17-18,26,29H,3-4,6,9-11,13H2,1-2H3,(H,25,31)(H,27,33)(H,28,32)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423438
PNG
(WO2005113580-Ex-40)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccccc1
Show InChI InChI=1S/C31H36N4O7/c1-18(2)14-24(35-30(39)25-16-21-22(33-25)10-7-11-27(21)41-3)29(38)34-23(15-20-12-13-32-28(20)37)26(36)17-42-31(40)19-8-5-4-6-9-19/h4-11,16,18,20,23-24,33H,12-15,17H2,1-3H3,(H,32,37)(H,34,38)(H,35,39)/t20-,23-,24-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.00E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423448
PNG
(WO2005113580-Ex-50)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(Cl)cc1O
Show InChI InChI=1S/C31H35ClN4O8/c1-16(2)11-23(36-30(41)24-14-20-21(34-24)5-4-6-27(20)43-3)29(40)35-22(12-17-9-10-33-28(17)39)26(38)15-44-31(42)19-8-7-18(32)13-25(19)37/h4-8,13-14,16-17,22-23,34,37H,9-12,15H2,1-3H3,(H,33,39)(H,35,40)(H,36,41)/t17-,22-,23-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.20E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423453
PNG
(WO2005113580-Ex-55)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CN=[N+]=[N-]
Show InChI InChI=1S/C24H31N7O5/c1-13(2)9-18(30-24(35)19-11-15-16(28-19)5-4-6-21(15)36-3)23(34)29-17(20(32)12-27-31-25)10-14-7-8-26-22(14)33/h4-6,11,13-14,17-18,28H,7-10,12H2,1-3H3,(H,26,33)(H,29,34)(H,30,35)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 9.40E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423469
PNG
(WO2006061714, P39.4 | WO2006061714-ID-14 | cmdc.20...)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N(C)C)C=O
Show InChI InChI=1S/C23H32N4O5/c1-14(2)11-18(22(30)24-15(13-28)9-10-21(29)27(3)4)26-23(31)19-12-16-17(25-19)7-6-8-20(16)32-5/h6-8,12-15,18,25H,9-11H2,1-5H3,(H,24,30)(H,26,31)/t15-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.80E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423415
PNG
(WO2005113580-Ex-10)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CCC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C25H34N4O6/c1-14(2)7-8-18(24(33)29-19(21(31)13-30)11-15-9-10-26-23(15)32)28-25(34)20-12-16-17(27-20)5-4-6-22(16)35-3/h4-6,12,14-15,18-19,27,30H,7-11,13H2,1-3H3,(H,26,32)(H,28,34)(H,29,33)/t15-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.30E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423417
PNG
(WO2005113580-Ex-11)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CCC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C26H36N4O6/c1-15(2)8-9-19(29-26(34)21-13-17-18(28-21)6-5-7-23(17)36-4)25(33)30-20(22(31)14-35-3)12-16-10-11-27-24(16)32/h5-7,13,15-16,19-20,28H,8-12,14H2,1-4H3,(H,27,32)(H,29,34)(H,30,33)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423424
PNG
(WO2005113580-Ex-21)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H]1CCCO1
Show InChI InChI=1S/C21H35N3O6/c1-21(2,3)11-15(24-20(28)17-6-5-9-30-17)19(27)23-14(16(25)12-29-4)10-13-7-8-22-18(13)26/h13-15,17H,5-12H2,1-4H3,(H,22,26)(H,23,27)(H,24,28)/t13-,14-,15-,17+/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a>1.00E+5n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423442
PNG
(WO2005113580-Ex-44)
Show SMILES COc1ccc(cc1)C(=O)OCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C32H38N4O8/c1-18(2)14-25(36-31(40)26-16-22-23(34-26)6-5-7-28(22)43-4)30(39)35-24(15-20-12-13-33-29(20)38)27(37)17-44-32(41)19-8-10-21(42-3)11-9-19/h5-11,16,18,20,24-25,34H,12-15,17H2,1-4H3,(H,33,38)(H,35,39)(H,36,40)/t20-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.30E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM420298
PNG
(PF-00835231 | PF-0835231 | WO2005113580-Ex-02 | WO...)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O6/c1-13(2)9-18(23(32)27-17(20(30)12-29)10-14-7-8-25-22(14)31)28-24(33)19-11-15-16(26-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,26,29H,7-10,12H2,1-3H3,(H,25,31)(H,27,32)(H,28,33)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
Purchase

PDB
UniChem
WIPO
n/an/an/an/a 5.10E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423411
PNG
(WO2005113580-Ex-05 | cmdc.202100576, 6c)
Show SMILES CC(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C23H30N4O5/c1-13(2)9-18(27-23(32)19-10-14-5-3-4-6-16(14)25-19)22(31)26-17(20(29)12-28)11-15-7-8-24-21(15)30/h3-6,10,13,15,17-18,25,28H,7-9,11-12H2,1-2H3,(H,24,30)(H,26,31)(H,27,32)/t15-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 2.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423441
PNG
(WO2005113580-Ex-43)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(cc1)C#N
Show InChI InChI=1S/C32H35N5O7/c1-18(2)13-25(37-31(41)26-15-22-23(35-26)5-4-6-28(22)43-3)30(40)36-24(14-21-11-12-34-29(21)39)27(38)17-44-32(42)20-9-7-19(16-33)8-10-20/h4-10,15,18,21,24-25,35H,11-14,17H2,1-3H3,(H,34,39)(H,36,40)(H,37,41)/t21-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.90E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423449
PNG
(WO2005113580-Ex-51)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(cc1F)C#N
Show InChI InChI=1S/C32H34FN5O7/c1-17(2)11-25(38-31(42)26-14-21-23(36-26)5-4-6-28(21)44-3)30(41)37-24(13-19-9-10-35-29(19)40)27(39)16-45-32(43)20-8-7-18(15-34)12-22(20)33/h4-8,12,14,17,19,24-25,36H,9-11,13,16H2,1-3H3,(H,35,40)(H,37,41)(H,38,42)/t19-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423454
PNG
(WO2005113580-Ex-56)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CNC(C)=O
Show InChI InChI=1S/C26H35N5O6/c1-14(2)10-20(31-26(36)21-12-17-18(29-21)6-5-7-23(17)37-4)25(35)30-19(22(33)13-28-15(3)32)11-16-8-9-27-24(16)34/h5-7,12,14,16,19-20,29H,8-11,13H2,1-4H3,(H,27,34)(H,28,32)(H,30,35)(H,31,36)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a>1.00E+5n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423457
PNG
(WO2005113580-Ex-58)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccccc1C#N
Show InChI InChI=1S/C32H35N5O7/c1-18(2)13-25(37-31(41)26-15-22-23(35-26)9-6-10-28(22)43-3)30(40)36-24(14-19-11-12-34-29(19)39)27(38)17-44-32(42)21-8-5-4-7-20(21)16-33/h4-10,15,18-19,24-25,35H,11-14,17H2,1-3H3,(H,34,39)(H,36,40)(H,37,41)/t19-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
PDB
UniChem
WIPO
n/an/an/an/a>1.00E+5n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423460
PNG
(WO2006061714, Example 2 | WO2006061714-ID-02)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O
Show InChI InChI=1S/C23H32N4O5/c1-13(2)9-18(22(30)25-15(12-28)10-14-7-8-24-21(14)29)27-23(31)19-11-16-17(26-19)5-4-6-20(16)32-3/h4-6,11,13-15,18,26,28H,7-10,12H2,1-3H3,(H,24,29)(H,25,30)(H,27,31)/t14-,15-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
PDB
UniChem
WIPO
n/an/an/an/a>1.00E+5n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423466
PNG
(WO2006061714, P39.1 | WO2006061714-ID-11 | cmdc.20...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C26H38N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,14,16-17,19-22H,10-13,15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 2.50E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423412
PNG
(WO2005113580-Ex-06)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C24H32N4O5/c1-14(2)10-19(28-24(32)20-11-15-6-4-5-7-17(15)26-20)23(31)27-18(21(29)13-33-3)12-16-8-9-25-22(16)30/h4-7,11,14,16,18-19,26H,8-10,12-13H2,1-3H3,(H,25,30)(H,27,31)(H,28,32)/t16-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 4.50E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423425
PNG
(WO2005113580-Ex-22)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CCl
Show InChI InChI=1S/C27H29ClN4O5/c1-37-24-9-5-8-19-18(24)14-22(30-19)27(36)32-21(12-16-6-3-2-4-7-16)26(35)31-20(23(33)15-28)13-17-10-11-29-25(17)34/h2-9,14,17,20-21,30H,10-13,15H2,1H3,(H,29,34)(H,31,35)(H,32,36)/t17-,20-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 7.50E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423427
PNG
(WO2005113580-Ex-25)
Show SMILES CC(C)C[C@H](N(C)C(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O5/c1-14(2)10-20(28(3)24(33)19-11-15-6-4-5-7-17(15)26-19)23(32)27-18(21(30)13-29)12-16-8-9-25-22(16)31/h4-7,11,14,16,18,20,26,29H,8-10,12-13H2,1-3H3,(H,25,31)(H,27,32)/t16-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.90E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423430
PNG
(WO2005113580-Ex-28)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COCc1ccccc1
Show InChI InChI=1S/C32H40N4O6/c1-20(2)15-27(36(3)32(40)26-17-23-24(34-26)11-8-12-29(23)41-4)31(39)35-25(16-22-13-14-33-30(22)38)28(37)19-42-18-21-9-6-5-7-10-21/h5-12,17,20,22,25,27,34H,13-16,18-19H2,1-4H3,(H,33,38)(H,35,39)/t22-,25-,27-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.60E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423431
PNG
(WO2005113580-Ex-29 | cmdc.202100576, 6d)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C25H34N4O6/c1-14(2)10-20(24(33)28-18(21(31)13-30)11-15-8-9-26-23(15)32)29(3)25(34)19-12-16-17(27-19)6-5-7-22(16)35-4/h5-7,12,14-15,18,20,27,30H,8-11,13H2,1-4H3,(H,26,32)(H,28,33)/t15-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.90E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423432
PNG
(WO2005113580-Ex-30)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COCc1ccccc1
Show InChI InChI=1S/C32H40N4O6/c1-32(2,3)17-26(36-30(39)25-16-22-23(34-25)11-8-12-28(22)41-4)31(40)35-24(15-21-13-14-33-29(21)38)27(37)19-42-18-20-9-6-5-7-10-20/h5-12,16,21,24,26,34H,13-15,17-19H2,1-4H3,(H,33,38)(H,35,40)(H,36,39)/t21-,24-,26-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 4.10E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423434
PNG
(WO2005113580-Ex-36)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(C)=O
Show InChI InChI=1S/C26H34N4O7/c1-14(2)10-20(30-26(35)21-12-17-18(28-21)6-5-7-23(17)36-4)25(34)29-19(22(32)13-37-15(3)31)11-16-8-9-27-24(16)33/h5-7,12,14,16,19-20,28H,8-11,13H2,1-4H3,(H,27,33)(H,29,34)(H,30,35)/t16-,19-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 6.70E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423439
PNG
(WO2005113580-Ex-41)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(C)cc1
Show InChI InChI=1S/C32H38N4O7/c1-18(2)14-25(36-31(40)26-16-22-23(34-26)6-5-7-28(22)42-4)30(39)35-24(15-21-12-13-33-29(21)38)27(37)17-43-32(41)20-10-8-19(3)9-11-20/h5-11,16,18,21,24-25,34H,12-15,17H2,1-4H3,(H,33,38)(H,35,39)(H,36,40)/t21-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.90E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423446
PNG
(WO2005113580-Ex-48)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(F)cccc1F
Show InChI InChI=1S/C31H34F2N4O7/c1-16(2)12-23(37-30(41)24-14-18-21(35-24)8-5-9-26(18)43-3)29(40)36-22(13-17-10-11-34-28(17)39)25(38)15-44-31(42)27-19(32)6-4-7-20(27)33/h4-9,14,16-17,22-23,35H,10-13,15H2,1-3H3,(H,34,39)(H,36,40)(H,37,41)/t17-,22-,23-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.40E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423452
PNG
(WO2005113580-Ex-54)
Show SMILES CC(C)C[C@H](NC(=O)c1nc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(Cl)cccc1Cl
Show InChI InChI=1S/C29H31Cl2N5O6/c1-15(2)12-22(36-28(40)25-33-19-8-3-4-9-20(19)34-25)27(39)35-21(13-16-10-11-32-26(16)38)23(37)14-42-29(41)24-17(30)6-5-7-18(24)31/h3-9,15-16,21-22H,10-14H2,1-2H3,(H,32,38)(H,33,34)(H,35,39)(H,36,40)/t16-,21-,22-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423465
PNG
(WO2006061714, P38.8 | WO2006061714-ID-10 | cmdc.20...)
Show SMILES CC(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=O
Show InChI InChI=1S/C22H28N4O4/c1-13(2)9-18(21(29)24-16(12-27)10-15-7-8-23-20(15)28)26-22(30)19-11-14-5-3-4-6-17(14)25-19/h3-6,11-13,15-16,18,25H,7-10H2,1-2H3,(H,23,28)(H,24,29)(H,26,30)/t15-,16-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 4.20E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423413
PNG
(WO2005113580-Ex-07)
Show SMILES CCCC[C@H](NC(=O)c1cc2c(OC)cccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CCl
Show InChI InChI=1S/C24H31ClN4O5/c1-3-4-6-17(23(32)29-18(20(30)13-25)11-14-9-10-26-22(14)31)28-24(33)19-12-15-16(27-19)7-5-8-21(15)34-2/h5,7-8,12,14,17-18,27H,3-4,6,9-11,13H2,1-2H3,(H,26,31)(H,28,33)(H,29,32)/t14-,17-,18-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a>4.20E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423420
PNG
(WO2005113580-Ex-16 | cmdc.202100576, 24b)
Show SMILES CC(C)(C)C[C@H](NC(=O)c1cc2ccccc2[nH]1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO
Show InChI InChI=1S/C24H32N4O5/c1-24(2,3)12-19(28-22(32)18-10-14-6-4-5-7-16(14)26-18)23(33)27-17(20(30)13-29)11-15-8-9-25-21(15)31/h4-7,10,15,17,19,26,29H,8-9,11-13H2,1-3H3,(H,25,31)(H,27,33)(H,28,32)/t15-,17-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.70E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423421
PNG
(WO2005113580-Ex-17)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C25H34N4O5/c1-25(2,3)13-20(29-23(32)19-11-15-7-5-6-8-17(15)27-19)24(33)28-18(21(30)14-34-4)12-16-9-10-26-22(16)31/h5-8,11,16,18,20,27H,9-10,12-14H2,1-4H3,(H,26,31)(H,28,33)(H,29,32)/t16-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 4.60E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423440
PNG
(WO2005113580-Ex-42)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1ccc(F)cc1
Show InChI InChI=1S/C31H35FN4O7/c1-17(2)13-24(36-30(40)25-15-21-22(34-25)5-4-6-27(21)42-3)29(39)35-23(14-19-11-12-33-28(19)38)26(37)16-43-31(41)18-7-9-20(32)10-8-18/h4-10,15,17,19,23-24,34H,11-14,16H2,1-3H3,(H,33,38)(H,35,39)(H,36,40)/t19-,23-,24-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 5.90E+3n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423444
PNG
(WO2005113580-Ex-46)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COC(=O)c1c(Cl)cccc1Cl
Show InChI InChI=1S/C31H34Cl2N4O7/c1-16(2)12-23(37-30(41)24-14-18-21(35-24)8-5-9-26(18)43-3)29(40)36-22(13-17-10-11-34-28(17)39)25(38)15-44-31(42)27-19(32)6-4-7-20(27)33/h4-9,14,16-17,22-23,35H,10-13,15H2,1-3H3,(H,34,39)(H,36,40)(H,37,41)/t17-,22-,23-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 350n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423450
PNG
(WO2005113580-Ex-52)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CNC(=O)c1ccccc1C#N
Show InChI InChI=1S/C32H36N6O6/c1-18(2)13-25(38-32(43)26-15-22-23(36-26)9-6-10-28(22)44-3)31(42)37-24(14-19-11-12-34-29(19)40)27(39)17-35-30(41)21-8-5-4-7-20(21)16-33/h4-10,15,18-19,24-25,36H,11-14,17H2,1-3H3,(H,34,40)(H,35,41)(H,37,42)(H,38,43)/t19-,24-,25-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 1.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423455
PNG
(WO2005113580-Ex-57)
Show SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CNS(C)(=O)=O
Show InChI InChI=1S/C25H35N5O7S/c1-14(2)10-19(30-25(34)20-12-16-17(28-20)6-5-7-22(16)37-3)24(33)29-18(11-15-8-9-26-23(15)32)21(31)13-27-38(4,35)36/h5-7,12,14-15,18-19,27-28H,8-11,13H2,1-4H3,(H,26,32)(H,29,33)(H,30,34)/t15-,18-,19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 2.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423459
PNG
(WO2006061714, Example 1 | WO2006061714-ID-01)
Show SMILES CC(C)C[C@H](NC(=O)OC(C)(C)C)C(=O)N[C@H](CO)C[C@@H]1CCNC1=O
Show InChI InChI=1S/C18H33N3O5/c1-11(2)8-14(21-17(25)26-18(3,4)5)16(24)20-13(10-22)9-12-6-7-19-15(12)23/h11-14,22H,6-10H2,1-5H3,(H,19,23)(H,20,24)(H,21,25)/t12-,13-,14-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a>1.00E+5n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423461
PNG
(WO2006061714-ID-03)
Show SMILES COC(O)[C@@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C24H34N4O6/c1-13(2)10-17(22(30)28-19(24(32)34-4)11-14-8-9-25-21(14)29)27-23(31)18-12-15-16(26-18)6-5-7-20(15)33-3/h5-7,12-14,17,19,24,26,32H,8-11H2,1-4H3,(H,25,29)(H,27,31)(H,28,30)/t14-,17-,19+,24?/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
KEGG
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 800n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423419
PNG
(WO2005113580-Ex-14)
Show SMILES COCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2c(OC)cccc2[nH]1
Show InChI InChI=1S/C26H36N4O6/c1-26(2,3)13-20(30-24(33)19-12-16-17(28-19)7-6-8-22(16)36-5)25(34)29-18(21(31)14-35-4)11-15-9-10-27-23(15)32/h6-8,12,15,18,20,28H,9-11,13-14H2,1-5H3,(H,27,32)(H,29,34)(H,30,33)/t15-,18-,20-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 3.20E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
3C-like proteinase (3CL-PRO)


(Human SARS coronavirus (SARS-CoV) (Severe acute re...)		BDBM423422
PNG
(WO2005113580-Ex-18)
Show SMILES CCOCC(=O)[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)(C)C)NC(=O)c1cc2ccccc2[nH]1
Show InChI InChI=1S/C26H36N4O5/c1-5-35-15-22(31)19(13-17-10-11-27-23(17)32)29-25(34)21(14-26(2,3)4)30-24(33)20-12-16-8-6-7-9-18(16)28-20/h6-9,12,17,19,21,28H,5,10-11,13-15H2,1-4H3,(H,27,32)(H,29,34)(H,30,33)/t17-,19-,21-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem
WIPO
n/an/an/an/a 2.00E+4n/an/an/an/a



Pfizer Inc.

WIPO


Assay Description
Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...

WIPO WO2005113580A1 (2005)


BindingDB Entry DOI: 10.7270/Q2PV6NRF
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%